Tarsus Pharmaceuticals Inc

TARSNASDAQ · USD
77.46USD0.00 (-0.81%)
5210

Tarsus Pharmaceuticals Inc (TARS) Covered Calls

As of September 21, 2026, TARS has 52 covered call opportunities in the coming three months. Return ranges from 5.0 to 76.1% until expiration. Annualized return ranges from 17.4 to 237.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $5,941.

Read more

Running TARS covered calls helps you generate consistent income from Tarsus Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Tarsus Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TARS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TARS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TARS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Tarsus Pharmaceuticals Inc covered call is worth writing.

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases.

Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Income-focused investors, long-term TARS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TARS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Tarsus Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile19.44% Subdued
  • Market cap (M$)3,624
  • 52 weeks high-15.37%
  • 52 weeks low43.84%
  • Analyst recommendationStrong Buy
    1.10
  • Target price$98.22
    26.80% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-03
  • P/E
  • Future P/E51.47
  • EPS (ttm)-1.08
  • EPS growth next 5 years

As of September 21, 2026

2026-11-2063110.0040.860.104.903201.0040.99237.49-0.13+0.2004.80
2026-11-2063100.0028.060.104.902201.0028.19163.30-0.13+0.2304.80
2027-03-19182135.0072.880.701.505761.0073.77147.95-0.90+0.1010.80
2026-10-162885.008.850.954.90786.0010.07131.21-1.22+0.35213.95
2026-11-206395.0021.650.504.901741.0022.29129.17-0.64+0.2604.40
2027-01-15119110.0040.860.104.903201.0040.99125.73-0.13+0.2094.80
2026-12-1891100.0028.060.604.902251.0028.83115.62-0.77+0.241334.30
2027-03-19182120.0053.670.804.904271.0054.69109.69-1.02+0.2014.10
2027-01-15119105.0034.460.255.002716.0034.78106.68-0.32+0.22144.75
2026-11-206390.0015.251.756.501366.0017.49101.35-2.24+0.3504.75

As of September 21, 2026

Sell covered calls with the data behind you

Find the best TARS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial